Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
1/2/2020
NHC and SATCM Issues Rules for Internal Price Practices of Medical Ins...
1/2/2020
AstraZeneca Granted Chinese Approval for Its Hyperkalaemia Drug ZS-9
12/31/2019
Financial-related Company News in Brief
12/31/2019
NMPA Announces Initiation of Drug Business Application System
12/30/2019
Bankrupt Achaogen Sells China Assets to Xuanzhu for $4.5M
12/30/2019
China's 'Seaweed' Alzheimer's Drug Is Now Available to Patients
12/30/2019
NMPA Issues the Principles and Procedures for Drug Sampling
12/30/2019
Boehringer Ingelheim Approved to Manufacture Tislelizumab in China for...
12/29/2019
China Adopts New Law to Promote Basic Medical and Health Care
12/27/2019
Recent Executive Moves
12/27/2019
China Launches Mental Health Initiative for Students
12/27/2019
NMPA Initiates Drug Import & Export Permit Management System
12/27/2019
Janssen Secured Chinese Approval of Psoriasis Drug Tremfya (Gussetizum...
12/26/2019
Sanofi Files NDA for the World's Atopic Dermatitis Biologic Dupilumab ...
12/26/2019
China Lists Lemazolam for Regulation as Class 2 Psychotropic
12/25/2019
CDE Solicits Comments on Guidelines for Clinical Protocol of Biosimila...
12/23/2019
NMPA Issues the Technical Guidelines for Clinical Comparability Studie...
12/23/2019
BeiGene Announces Acceptance of a China sNDA for REVLIMID in Relapsed ...
12/23/2019
Amid Trade War, China Lowers Import Tariffs on 850 Products Including ...
12/23/2019
Roche Eyes China for Sarepta's DMD Gene Therapy
12/20/2019
Chi-Med Gets Priority Review for 'Surufatinib' in China
12/20/2019
InxMed Cleared to Initiate Phase I Trial for Anticancer FAK Inhibitor
12/20/2019
TRACON, 3D Medicines and Alphamab Enter Partnership for Subcutaneous P...
12/20/2019
Wuxi Biologics and Convalife Form Partnership to Develop Innovative An...
12/19/2019
Genzyme's Orphan Drug Fabrazyme (Agalsidase Beta) Approved in China
12/19/2019
Recent Announcement for A More Effective Intellectual Property Protect...
12/19/2019
PHIIC: Data Snapshots of Chinese Pharma Market 2013-2019E
12/19/2019
Performance Snapshots of HKSE-Listed Pre-profit Biotech Startups
12/19/2019
Shanghai Launches New Policy to Support Building of Research Hospitals
12/18/2019
Moffitt Cancer Center CEO, Others Resign Over China Ties
Page:
125
/
357
Total number of articles:
10689
:
[First]
[<<]
[123]
[124]
[125]
[126]
[127]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit